Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study is being done to learn what effects (good and bad) bevacizumab in conjunction with
carboplatin/paclitaxel and radiation therapy has on patients with non-small cell lung cancer
(NSCLC).
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital